{"organizations": [], "uuid": "6e8586875fca0b567d9bca5bbf80d61f3895ea66", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cbs8.com", "main_image": "", "site_section": "http://www.cbs8.com/category/266385/technology-general", "section_title": "Technology Press Releases from PRWeb - CBS News 8 - San Diego, CA News Station - KFMB Channel 8", "url": "http://www.cbs8.com/story/30346918/fusion-antibodies-to-attend-hah-2015", "country": "US", "title": "Fusion Antibodies to Attend HAH 2015", "performance_score": 0, "site": "cbs8.com", "participants_count": 1, "title_full": "Fusion Antibodies to Attend HAH 2015 - CBS News 8 - San Diego, CA News Station - KFMB Channel 8", "spam_score": 0.0, "site_type": "news", "published": "2015-10-26T11:11:00.000+02:00", "replies_count": 0, "uuid": "6e8586875fca0b567d9bca5bbf80d61f3895ea66"}, "author": "cbs8", "url": "http://www.cbs8.com/story/30346918/fusion-antibodies-to-attend-hah-2015", "ord_in_thread": 0, "title": "Fusion Antibodies to Attend HAH 2015", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "Fusion Antibodies have announced that the company will be attending the 2015 Human Antibodies and Hybridomas Conference.\n(PRWEB UK) 26 October 2015\nFusion Antibodies today announce that they will be attending the 2015 Human Antibodies and Hybridomas Conference, to be held 28-30th of October at the University of Lausanne, Switzerland. Conference activities will include keynote lectures, presentations and contributed papers. The event will bring together top scientists from universities, bioscience companies and research institutes across Europe, North America and Asia.\nHAH 2015 will cover nine main topics:\n Anti-infective antibodies Autoimmunity Cancer Clinical applications Emerging technologies Infectious diseases Intellectual property and legal issues Molecular biology Therapeutic antibodies\nThis will be Fusion Antibodies’ 9th year in attendance at the event. Managing Director, Dr Paul Kerr is part of the Scientific Advisory committee and Technical Director Dr Richard Buick will be presenting “Fast track humanization of rabbit antibodies: Optimization of an algorithm based on a broad rabbit B-cell repertoire.”\n //www.prweb.com/releases/2015/10/prweb13040572.htm\n ", "external_links": ["http://www.prweb.com/releases/2015/10/prweb13040572.htm"], "published": "2015-10-26T11:11:00.000+02:00", "crawled": "2015-10-26T10:49:32.176+02:00", "highlightTitle": ""}